Comparison of contrast effect on the cochlear perilymph after intratympanic and intravenous gadolinium injection

American Journal of Neuroradiology

Volumn 33, Issue 4, 2012, Pages 773-778

  Yamazaki, Masahiro ^a   Naganawa, S ^a   Tagaya, M ^a   Kawai, H ^a   Ikeda, M ^b   Sone, M ^a   Teranishi, M ^a   Suzuki, H ^a   Nakashima, T ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GADOTERIDOL;

ADOLESCENT; ADULT; AGED; ARTICLE; COCHLEA; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLA OBLONGATA; MENIERE DISEASE; PERILYMPH; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COCHLEA; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MENIERE DISEASE; MIDDLE AGED; PERILYMPH; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TYMPANIC MEMBRANE; YOUNG ADULT;

EID: 84860237732     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2821     Document Type: Article

References (31)

1. Melhem ER, Jara H, Eustace S. Fluid-attenuated inversion recovery MR imaging: identification of protein concentration threshold for CSF hyperintensity. AJR Am J Roentgenol 1997;169:859-62 (Pubitemid 27365006)
2. Mishra AM, Reddy SJ, Husain M, et al. Comparison of the magnetization transfer ratio and fluid-attenuated inversion recovery imaging signal intensity in differentiation of various cystic intracranial mass lesions and its correlation with biological parameters. J Magn Reson Imaging 2006;24:52-56
3. Naganawa S, Koshikawa T, Nakamura T, et al. Comparison of flow artifacts between 2D-FLAIR and 3D-FLAIR sequences at 3T. Eur Radiol 2004;14: 1901-08 (Pubitemid 39386640)
4. Sugiura M, Naganawa S, Sato E, et al. Visualization of a high protein concentration in the cochlea of a patient with a large endolymphatic duct and sac, using three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging. J Laryngol Otol 2006;120:1084-86 (Pubitemid 46132600)
5. Sugiura M, Naganawa S, Teranishi M, et al. Inner ear hemorrhage in systemic lupus erythematosus. Laryngoscope 2006;116:826-28 (Pubitemid 44318045)
6. Otake H, Sugiura M, Naganawa S, et al. 3D-FLAIR magnetic resonance imaging in the evaluation of mumps deafness. Int J Pediatr Otorhinolaryngol 2006;70:2115-17 (Pubitemid 44716360)
7. Sugiura M, Naganawa S, Teranishi M, et al. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings in patients with sudden sensorineural hearing loss. Laryngoscope 2006;116:1451-54 (Pubitemid 44181463)
8. Sone M, Mizuno T, Sugiura M, et al. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging investigation of inner ear disturbances in cases of middle ear cholesteatoma with labyrinthine fistula. Otol Neurotol 2007;28:1029-33 (Pubitemid 350191072)
9. Sugiura M, Naganawa S, Sone M, et al. Three-dimensional fluid attenuated inversion recovery magnetic resonance imaging findings in a patient with cochlear otosclerosis. Auris Nasus Larynx 2008;35:269-72 (Pubitemid 351474570)
10. Yamazaki M, Naganawa S, Kawai H, et al. Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 2009;51:855-63
11. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Ménière's disease. Laryngoscope 2007;117:415-20 (Pubitemid 46407747)
12. Naganawa S, Sugiura M, Kawamura M, et al. Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadoliniumdiethylene- triamine pentaacetic acid. AJNR Am J Neuroradiol 2008;29:724 -26. Epub 2008 Jan 9
13. Naganawa S, Satake H, Iwano S, et al. Imaging endolymphatic hydrops at 3 Tesla using 3D-FLAIR with intratympanic Gd-DTPA administration. Magn Reson Med Sci 2008;7:85-91
14. Teranishi M, Naganawa S, Katayama N, et al. Image evaluation of endolymphatic space in fluctuating hearing loss without vertigo. Eur Arch Otorhinolaryngol 2009;266:1871-77
15. Yamazaki M, Naganawa S, Kawai H, et al. Signal alteration of the cochlear perilymph on 3 different sequences after intratympanic Gd-DTPA administration at 3 Tesla: comparison of 3D-FLAIR, 3D-T1-weighted imaging, and 3D-CISS. Magn Reson Med Sci 2010;9:65-71
16. Nakashima T, Naganawa S, Teranishi M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière's disease. Acta Otolaryngol 2010;130:338-43
17. Tagaya M, Teranishi M, Naganawa S, et al. 3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010;130:665-69
18. Schwaber MK. Transtympanic gentamicin perfusion for the treatment of Ménière's disease. Otolaryngol Clin North Am 2002;35:287-95 (Pubitemid 34760221)
19. De Stefano A, Dispenza F, De Donato G, et al. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Ménière's disease. Am J Otolaryngol 2007;28:289-93 (Pubitemid 47362435)
20. Haynes DS, O'Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3-15 (Pubitemid 46066055)
21. Ahn JH, Han MW, Kim JH, et al. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 2008;128:128-31
22. Naganawa S, Komada T, Fukatsu H, et al. Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006;16:733-37 (Pubitemid 44149387)
23. Zou J, Poe D, Bjelke B, et al. Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Otolaryngol Suppl 2009;560:22-31
24. Naganawa S, Ishihara S, Iwano S, et al. Estimation of gadolinium-induced T1-shortening with measurement of simple signal intensity ratio between the cochlea and brain parenchyma on 3D-FLAIR: correlation with T1 measurement by TI scout sequence. Magn Reson Med Sci 2010;9:17-22
25. Yoshioka M, Naganawa S, Sone M, et al. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30:645-48
26. Naganawa S, Kawai H, Sone M, et al. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010;9:73-80
27. Tagaya M, Yamazaki M, Teranishi M, et al. Endolymphatic hydrops and blood-labyrinth barrier in Ménière's disease. Acta Otolaryngol 2011;131:474-79
28. Kakigi A, Nishimura M, Takeda T, et al. Effects of gadolinium injected into the middle ear on the stria vascularis. Acta Otolaryngol 2008;128:841-45 (Pubitemid 351957659)
29. Fukuoka H, Tsukada K, Miyagawa M, et al. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere's disease. Acta Otolaryngol 2010;130:10-16
30. Fiorino F, Pizzini FB, Beltramello A, et al. MRI performed after intratympanic gadolinium administration in patients with Ménière's disease: correlation with symptoms and signs. Eur Arch Otorhinolaryngol 2011;268:181-87
31. Horii A, Osaki Y, Kitahara T, et al. Endolymphatic hydrops in Meniere's disease detected by MRI after intratympanic administration of gadolinium: comparison with sudden deafness. Acta Otolaryngol 2011;131:602- 09. Epub 2011 Feb 23